PCVX · Vaxcyte, Inc. · Documents
$63.23
-3.00 (-4.53%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$9.86B
Shares
148.81M
Volume · Oct 21
3.27M
Avg daily vol (3M)
1.95M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-05-11 | 2021-03-31 | |
| 8-K | — | 2021-05-11 | — | |
| DEF 14A | — | 2021-04-14 | 2021-06-02 | |
| DEFA14A | — | 2021-04-14 | — | |
| 8-K | — | 2021-03-29 | — | |
| 10-K | — | 2021-03-29 | 2020-12-31 | |
| 8-K | — | 2021-03-25 | 2021-03-24 | |
| 8-K | — | 2021-01-25 | 2021-01-21 | |
| 8-K | — | 2020-12-22 | 2020-12-16 | |
| 8-K | — | 2020-11-12 | — | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 10-Q | — | 2020-08-12 | 2020-06-30 | |
| 8-K | — | 2020-08-12 | — | |
| 8-K | — | 2020-06-16 | — | |
| S-1/A | — | 2020-06-08 | — | |
| S-1 | — | 2020-05-22 | — |
Showing 101–116 of 116 filings
Key facts
CIK
1649094
CUSIP
92243G108
13F (30d)
33 filings
33 filers
Visit website
Investor relations